Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Cancer
- Disease
- Therapeutic
- Pharmaceuticals
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 7151
License Grant
The Licensor, a University, does hereby validly sell, assign, transfer, grant, bargain, deliver and convey to Recipient, the Licensor's entire right, title and interest in and to the Technology.
License Property
The Licensor has certain proprietary rights in research, development and other technology, including process and materials relating to cellular immunotherapy, and, more specifically, cancer antigen immunotherapy, including, without limitation, any and all data, discoveries, inventions, technical information and know-how relating to and disclosed in cellular immunotherapy, owned by the Licensor and invented by Recipient.
Field of Use
Recipient is interested in obtaining the rights to develop the Technology so that products and services relating to the Technology might become commercially viable.
IPSCIO Record ID: 7101
License Grant
The Licensor, a University, does hereby validly sell, assign, transfer, grant, bargain, deliver and convey to Recipient, the Licensor's entire right, title and interest in and to the Technology.
License Property
KUMC has certain proprietary rights in research, development and other technology, including process and materials relating to cellular immunotherapy, and, more specifically, cancer antigen immunotherapy (the Technology), including, without limitation, any and all data, discoveries, inventions, technical information and know-how relating to and disclosed in cellular immunotherapy, owned by the Licensor and invented by Recipient.
Field of Use
Recipient is interested in obtaining the rights to develop the Technology so that products and services relating to the Technology might become commercially viable.
IPSCIO Record ID: 6900
License Grant
The Licensor, a University, does hereby validly sell, assign, transfer, grant, bargain, deliver and convey to the Licensee, right, title and interest in and to the Technology as a result of studies and development relating to the Technology performed at the Licensor by the Licensee and which utilized Licensor resources.
License Property
The University may have certain rights in research, development and other technology relating to cellular immunotherapy, and, more specifically, cancer antigen immunotherapy including, without limitation, any and all data, discoveries, inventions, technical information and know-how relating to cellular immunotherapy, owned by the Licensor and invented by the Licensee.
IPSCIO Record ID: 4225
License Grant
The Licensor, a University, does hereby validly sell, assign, transfer, grant, bargain, deliver and convey to the Licensee, right, title and interest in and to the Technology as a result of studies and development relating to the Technology performed at the Licensor by the Licensee and which utilized Licensor resources.
License Property
The University may have certain rights in research, development and other technology relating to cellular immunotherapy, and, more specifically, cancer antigen immunotherapy as described in WSU Invention Disclosure # 00-506 including, without limitation, any and all data, discoveries, inventions, technical information and know-how relating to cellular immunotherapy, owned by the Licensor and invented by the Licensee.
Field of Use
The Licensee is interested in obtaining the rights to develop the Technology so that products and services relating to the Technology might become commercially available.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
